Gilde Healthcare Services invests in nursing homes - Gilde Healthcare

Gilde Healthcare Services invests in nursing homes

October 25, 2010

Utrecht, The Netherlands – Gilde Healthcare Services (Gilde), a growth capital fund specialised in Healthcare Services, has acquired a significant minority stake in elderly care provider Stepping Stones Home & Care (Stepping Stones) of the Netherlands to fund further growth of the company.

Stepping Stones operates a chain of nursing homes providing care for elderly with Alzheimer’s disease and related conditions that need continuous support. The nursing homes offer a safe, protected and continuous care environment with affordable services tailored to the needs of residents (www.steppingstonesbv.nl).

Stepping Stones founding managers Arthur Scherpenzeel and Christiaan Sap commented:

“We are thrilled with the investment from Gilde. This investment not only enables us to expand the number of locations but we will also benefit from Gilde’s hands-on approach and healthcare expertise.

Jasper van Gorp, Partner of the Gilde Healthcare Services fund said:

“We were impressed by Stepping Stones’ ability to provide a very high quality yet affordable care home service. We believe that there is a considerable need for this type of service which can co-exist alongside care provided by the public sector in the Netherlands. This investment is aligned perfectly with our investment focus on high growth healthcare services companies.

More news

Hermann Medizintechnik joins SPI – the specialized MedTech CDMO platform sponsored by Gilde Healthcare

Hermann Medizintechnik ("Hermann") has officially joined Gilde Healthcare's group of contract manufacturers for complex surgical instruments and implants ("SPI"), marking another significant milestone for SPI. With Hermann, SPI grows to more than 500 highly skilled...
September 10, 2026

BENTEC Endoscopy joins Gilde Healthcare’s contract manufacturing group for surgical instruments and implants

Gilde Healthcare's group of contract manufacturers for complex surgical instruments and implants ("SPI") is acquiring BENTEC Endoscopy ("BENTEC"). The transaction marks another significant milestone in building a leading group for the contract manufacturing of surgical...
August 27, 2026

Gilde Healthcare company Amphista Therapeutics announces FDA clearance of IND application for AMX-883, its lead Targeted Glue™ degrader for acute myeloid leukaemia

Amphista to initiate its first clinical trial for AMX-883, a potent, orally bioavailable DCAF16-dependent degrader of BRD9, for acute myeloid leukaemia (AML) in H2 2026 The Phase 1 monotherapy dose-escalation and optimisation trial will enrol...
June 11, 2026